Xenobiotic inducible regions of the human arylamine N-acetyltransferase 1 and 2 genes.
Arylamine N-acetyltransferase (NAT) enzymes catalyze the addition of an acetyl group from acetyl-CoA to a terminal nitrogen on a suitable substrate such as environmentally relevant compounds and pharmaceuticals. In human, there are two highly polymorphic active allozymes, NAT1 and -2, and one inactive pseudogene, NATP. The expression of these enzymes is tissue-specific such that NAT1 is ubiquitously expressed and NAT2 is confined mainly to liver and colorectal tissues. We hypothesized that these genes would be tissue-specifically transcriptionally regulated, and so we isolated putative proximal control regions for both the NAT genes, which were inserted into luciferase vectors and transiently transfected into human liver and bladder cells. The transfected cells were dosed with 4-aminosalicylic acid, sulfamethazine or solvent and the resulting luciferase activity was measured. We found that both NAT1 and -2 regions were inducible in liver cells by both xenobiotics but only one of the NAT1 regions was inducible again by both xenobiotics in bladder cells. These results suggest that the NAT genes may be tissue-specifically transcriptionally regulated.
Mitchell
Kent R
KR
Department of Environmental Health, College of Medicine, University of Cincinnati Medical Center, Cincinnati, OH, USA. kmitchell@woodhudson.org
Warshawsky
David
D
D010131:Aminosalicylic Acid / Q000494:pharmacology*; D001191:Arylamine N-Acetyltransferase / Q000235:genetics*; D001483:Base Sequence; D002460:Cell Line; D004790:Enzyme Induction / Q000187:drug effects; D017930:Genes, Reporter / Q000235:genetics; D006801:Humans; D008969:Molecular Sequence Data; D011401:Promoter Regions, Genetic / Q000235:genetics; D013418:Sulfamethazine / Q000494:pharmacology*; D015262:Xenobiotics / Q000494:pharmacology*
D015262:Xenobiotics; D013418:Sulfamethazine; D010131:Aminosalicylic Acid; D001191:Arylamine N-Acetyltransferase